Cormorant Asset Management, LP
Transaction: 04/28/2026
SELL
Change
-109,331
Price
$89.50
Filing
04/30/2026
Type
SELL
Bright Minds Biosciences Inc.
DRUG • Biotechnology
$65.16
▼ -2.86 (-4.20%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$640.55M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 36.1Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 19, 2026, 12:10 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$65.16
Change-4.20%
Shares Out9.83M
Market Cap$640.55M
52W Range38.00 - 123.75
Beta0.09
P/E-17.75
P/S0.00
P/B2.45
P/FCF-79.50
EV/Sales0.00
EV/EBITDA-42.73
Price$65.16
Change-4.20%
Shares Out9.83M
Market Cap$640.55M
52W Range38.00 - 123.75
Beta0.09
P/E-17.75
P/S0.00
P/B2.45
P/FCF-79.50
EV/Sales0.00
EV/EBITDA-42.73
EV/FCF-69.97
Earnings Yield-1.41%
FCF Yield-1.26%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio36.10
Quick Ratio36.10
Target$182.50
Target Upside180.08%
Target Median$182.50
Target Range145.00 - 220.00
Volume127.69K
Avg Volume272.36K
EPS Surprise0.37
Investment DNA
How strong this company looks for long-term investors
39
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
44/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 36.1Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 4 analyst votes · 2026-09-05
100/100
Bullish
Bullish
4
Hold
0
Bearish
0
Price Target
2026-08-19
Low
$145.00
Mean
$182.50
Median
$182.50
High
$220.00
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
Cormorant Asset Management, LP
Transaction: 11/04/2024
BUY
Change
+184,331
Price
$21.70
Filing
11/06/2024
Type
BUY
Cormorant Asset Management, LP
Transaction: 10/16/2024
BUY
Change
+39,743
Price
$23.21
Filing
10/17/2024
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP | SELL | -109,331 | $89.50 | 04/28/2026 | 04/30/2026 |
| Cormorant Asset Management, LP | BUY | +184,331 | $21.70 | 11/04/2024 | 11/06/2024 |
| Cormorant Asset Management, LP | BUY | +39,743 | $23.21 | 10/16/2024 | 10/17/2024 |
| Cormorant Asset Management, LP | OTHER | 0 | Not reported | 10/15/2024 | 10/17/2024 |